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A B S T R A C T
The inﬂuenza A virus, which has an RNA genome, requires RNA-dependent RNA polymerase for transcription
and replication. The polymerase is comprised of the subunits PA, PB1, and PB2. The C-terminal RNA-binding
domain in PB2 contains lysine 627 (PB2 627), which is associated with pathogenicity and host range. However,
the structure and molecular mechanism of PB2 627 in solution remain obscure. Here, we investigated PB2 627 in
solution by nuclear magnetic resonance (NMR) and detected inhomogeneity in the intensities of backbone amide
proton signals due to local ﬂuctuations in structure. To characterize the eﬀects of chemical chaperones on
spectral data and improve the data quality, we tested 20 diﬀerent additives, including L-arginine L-glutamate
salt, (L-arginine)2SO4, glycerol, β-octylglucoside, 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfo-
nate, Na2SO4, 1,5-diaminopentane, 1,4-diaminobutane, trehalose, sucrose, glycine, trimethylamine N-oxide, β-
alanine, L-α-alanine, hydroxyectoine, betaine, L-proline, and non-detergent sulfobetaine 195, 201, and 256. We
evaluated the quality of the resulting spectra by calculating the standard deviation and average of the ratio of
signal intensities to noise level of amide peaks, as well as the ratio of the standard deviation to the average.
NMR-proﬁle analysis revealed diverse eﬀects of additives on the dynamic properties of PB2 627. Based on such
criteria, we found that small osmolytes such as glycine and L-α-alanine reduced structural ﬂuctuations and
improved the quality of spectral data, which is likely to facilitate a detailed NMR-based structural analysis. The
methodology developed here may also be more generally useful for evaluating the eﬀects of chemical chaper-
ones on the structural integrity of proteins.
1. Introduction
In 1918, a pandemic of inﬂuenza A virus resulted in ten million
deaths worldwide [1]. Strategies to prevent future pandemics must
therefore be formulated [2,3]. Although inhibitors of the viral neur-
aminidase and M2 ion channel are widely used for treatment [4,5],
some adverse side eﬀects have been reported, and drug resistance has
emerged [6,7]. The viral RNA-dependent RNA polymerase is a very
promising alternative drug target because it is required for transcription
and replication of viral genes. To initiate viral gene transcription, a 5′
RNA fragment of 10–15 nucleotides is used as a primer [8], which is
recognized by the C-terminal domain in the PB2 subunit of the RNA
polymerase along with promoter RNA [9]. This domain also contains
the lysine 627 residue, which is associated with high pathogenicity and
restricted host range. This domain is thus called PB2 627 [10].
Protein tertiary structures are a valuable resource in drug devel-
opment, and crystal structures of PB2 627 have been determined
[11–13]. Nevertheless, it is equally important to investigate the struc-
ture and dynamics of PB2 627 in solution in order to understand its
mechanism of action, and to design novel drugs against it. In turn, such
an investigation would require optimal conditions for solution nuclear
magnetic resonance (NMR). In this study, we collected 2D NMR spectra
http://dx.doi.org/10.1016/j.bbrep.2017.09.003
Received 30 November 2016; Received in revised form 31 March 2017; Accepted 15 September 2017
⁎ Corresponding author at: Institute for Health Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan.
⁎⁎ Corresponding author at: Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan.
E-mail addresses: ysk.kt@tokushima-u.ac.jp (Y.S. Kato), kuzuhara@ph.bunri-u.ac.jp (T. Kuzuhara).
Abbreviations: CHAPS, 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate; DTT, dithiothreitol; Irel, ratio of signal intensity to noise level; HSQC, heteronuclear single
quantum coherence; NDSB, non-detergent sulfobetaine; NMR, nuclear magnetic resonance; PB2 627, C-terminal RNA-binding domain of PB2 containing lysine 627; S/N, signal-to-noise
ratio; TMAO, trimethylamine N-oxide
Biochemistry and Biophysics Reports 12 (2017) 129–134
Available online 20 September 2017
2405-5808/ © 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).
MARK
from PB2 627 and found that the quality of the initial spectra is unlikely
to be suﬃcient for higher-dimensional NMR, which is necessary to
analyze structure and dynamics, but has a lower signal-to-noise ratio
(S/N) than 2D NMR.
Previous studies demonstrated that diverse additives, such as salts,
sugars, amino acids, methylamines, chaotropic agents, and detergents,
improved NMR spectra of proteins [14,15]. L-arginine L-glutamate salt
and non-detergent sulfobetaines (NDSBs) are frequently used to this end
[16,17]. Diverse amino acids have been reported to improve protein
stability [18–20]. Diamines were reported to prevent thermal ag-
gregation and inactivation of lysozyme [21]. Amino acids, methyla-
mines, and chaotropes are categorized as osmolytes. Osmolytes are
osmotically active solutes in organisms that have evolved to resist water
stress such as high or low salt concentrations, desiccation, or freezing
[22]. Most osmolytes are small organic compounds. However, to our
knowledge, no reports have described the comprehensive testing of
numerous additives and their eﬀects on protein NMR spectra. Thus, we
experimented with 20 diﬀerent compounds to improve the spectra of
PB2 627, ﬁnding that osmolyte additives such as neutral amino acids
and derivatives can improve the quality of spectral data. We anticipate
that our results and methodologies will prove generally useful for im-
proving protein NMR spectra and for evaluating the ability of various
compounds to reduce structural ﬂuctuations of proteins.
2. Materials and methods
2.1. Sample preparation
Construction of a plasmid for expressing His6-tagged PB2 627
(amino acids 535–759) was described previously [11,12]. 15N-labeled
PB2 627 was produced in Rosetta 2 (DE3) E. coli (EMD Millipore,
Billerica, MA), following a protocol based on M9 media containing
trace elements [23], with some modiﬁcation. Brieﬂy, cells were lysed
by sonication in 20 mM sodium phosphate (pH 7.6), 250 mM NaCl,
7.5% glycerol, 20 mM imidazole pH 8.0, 1 mM dithiothreitol (DTT),
protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO), and lyso-
zyme (Seikagaku Corp., Tokyo, Japan). Lysates were clariﬁed by cen-
trifugation at 50,000 × g, and the supernatant was loaded on Ni-NTA
agarose (Qiagen, Hilden, Germany) equilibrated with 20 mM sodium
phosphate (pH 7.3), 250 mM NaCl, 5% glycerol, and 20 mM imidazole
(pH 8.0). After extensive washing, PB2 627 was eluted with 20 mM
sodium phosphate (pH 7.0), 250 mM NaCl, 1 mM DTT, 10% glycerol,
and 200 mM imidazole (pH 8.0). After addition of 0.1% Tween 20 and
thrombin (GE Healthcare Bio-Sciences Corp., Piscataway, NJ), the
protein was dialyzed against 20 mM Tris-HCl (pH 6.5), 50 mM NaCl,
10% glycerol, and 0.5 mM DTT, and then puriﬁed by cation-exchange
on HiPrep CM (GE Healthcare). Subsequently, the protein was con-
centrated using a Vivaspin centrifugal concentrator (Sartorius, Goet-
tingen, Germany) and loaded on Superdex 75 16/600 (GE Healthcare)
equilibrated with 20 mM sodium phosphate (pH 6.5), 150 mM NaCl,
4% glycerol, and 1 mM DTT. Finally, puriﬁed samples were con-
centrated and dialyzed against 20 mM sodium phosphate (pH 6.5), 7%
D2O, 50 mM NaCl, and 1 mM DTT.
2.2. NMR
1H–15N heteronuclear single quantum coherence (HSQC) experi-
ments were performed at 20 °C using an Inova 600 spectrometer
equipped with a Cold Probe (Agilent Technologies, Santa Clara, CA)
and an Avance-III 950 system (Bruker, Billerica, MA). The ﬁnal con-
centration of PB2 627 was 3.0 mg/mL, although PB2 627 is stable and
can be crystallized at concentrations of up to 10 mg/mL [11]. Spectra
were collected with or without 0.2 M (L-arginine)2SO4, Na2SO4 or L-
arginine L-glutamate salt; 4% glycerol; 25 mM β-octylglucoside; 10 mM
CHAPS; 0.1 M 1,5 diaminopentane or 1,4 diaminobutane; 20% treha-
lose; or 0.5 M sucrose, glycine, trimethylamine N-oxide (TMAO), β-
alanine, L-α-alanine, hydroxyectoine, betaine, L-proline, or NDSB 195,
201, or 256 (Supplementary Table 1). NMR tubes were siliconized prior
to use to prevent protein aggregation. Data processing and analysis
were performed with the NMRpipe and Sparky 3.115 programs [24,25].
Relative intensity (Irel) denotes the ratio of signal intensity to noise level
according to Pedrini et al. [26].
3. Results
3.1. Flash 2D NMR
PB2 627 contains a nuclear localization signal, a C-terminal RNA-
binding domain, and lysine 627 that determines the pathogenicity and
host range. We puriﬁed PB2 627 to homogeneity using immobilized Ni-
aﬃnity, cation-exchange, and gel-ﬁltration chromatography
(Supplementary Fig. 1).
We carried out a 1H–15N heteronuclear single quantum coherence
experiment by NMR. Fourier transformation and processing were then
performed to obtain a spectrum. The spectrum contained numerous
sharp, well-dispersed peaks from backbone amides (Supplementary
Fig. 2A), suggesting that PB2 627 is monomeric, and that the global fold
is stable in aqueous solution. However, the number of peaks diminished
when the spectrum was contoured at a higher threshold
(Supplementary Fig. 2B), indicating that the peaks had diﬀerent in-
tensities. Weak amide signals arise from line broadening due to local
conformational changes over a time scale ranging from microseconds to
milliseconds. Structural polymorphisms and transient oligomerization/
aggregation of proteins can also cause weak signals. In contrast, strong
amide signals arise from unstructured regions. Thus, inhomogeneity in
signal intensities is due to inhomogeneity in structure and structural
dynamics of proteins. Indeed, the PB2 627 construct contains a C-
terminal segment that was not observed in the crystal structure. This
presumably unstructured region should provide strong signals at
8.0–8.5 ppm of the 1H axis in the HSQC spectrum. It is therefore likely
that structural analysis using this sample will be challenging. In addi-
tion, we anticipate that many amides with low-intensity peaks will
become undetectable in higher-dimensional NMR, which has a lower S/
N than does HSQC.
3.2. Eﬀects of additives
To reduce inhomogeneity in the intensity of amide peaks, we in-
vestigated 20 diﬀerent additives that may homogenize the structure
and dynamic properties of PB2 627 and improve the quality of NMR
data. We tested the diamines 1,4-diaminobutane, and 1,5-diamino-
pentane; the detergents β-octylglucoside and CHAPS; the sugars and
polyols glycerol, trehalose, and sucrose; the salt Na2SO4; NDSBs 195,
201, and 256; and the amino acids and amino-acid derivatives hydro-
xyectoine, (L-arginine)2SO4, L-arginine L-glutamate salt, TMAO, betaine,
L-proline, L-α-alanine, β-alanine and glycine. Prior to investigating the
eﬀects of these additives on amide peak homogeneity, we studied dif-
ferent salt concentrations and pH values, which were not eﬀective.
HSQC spectra of suﬃcient quality for further analysis were obtained
in the presence of 17 diﬀerent additives (Supplementary Fig. 3). Spectra
collected in the presence of β-octylglucoside, sucrose, and NDSB 256
were not suitable for further analysis, presumably because PB2 627 was
denatured or aggregated under these conditions. Spectra obtained in
the presence of L-arginine L-glutamate salt and glycine represented ex-
amples with contrastive spectral changes. L-arginine L-glutamate salt
caused a shift in position for many amide peaks (as shown in the boxes
in Fig. 1A) and further reduced the signal intensity of amide peaks that
were already weak. As a result, many peaks in the peripheral region of
the spectrum diminished or disappeared (Fig. 1A), indicating that L-
arginine L-glutamate salt increased the structural inhomogeneity of PB2
627. In contrast, glycine did not move or quench most peripheral peaks
(Fig. 1B).
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3.3. Quantitative analysis
To quantitatively analyze the inhomogeneity of peak intensities, we
picked 210 backbone signals that were recognized as peaks by Sparky 3.
While the expected number of backbone amide signals was 215, it is
quite diﬃcult to pick a complete set of backbone amide signals due to
extensive signal overlaps and the existence of numerous weak peaks
that could not be clearly distinguished from noise. Thus, we anticipated
that PB2 627 contains structural polymorphisms. We calculated the
ratio of the signal intensities of individual resonances to the average
noise, Irel, in order to measure the S/N ratios of the individual re-
sonances, as well as their standard deviations to measure in-
homogeneities in the signal intensities. We found that 11 additives
decreased the standard deviation of Irel for the 210 peaks compared
with the no-additive condition (Fig. 2A). Furthermore, we found that
the average Irel decreased in many cases (Fig. 2B), suggesting that the
decrease in standard deviation may be due to a lower average Irel value.
We therefore calculated the ratio of the standard deviation to the
average and found that the ratio increased in the presence of 10 ad-
ditives, compared with the no-additive condition (Fig. 2C), suggesting
that these compounds increased the inhomogeneity of Irel. The ratio
increased particularly in the presence of CHAPS, trehalose, Na2SO4, (L-
arginine)2SO4, and L-arginine L-glutamate salt. In contrast, neutral
amino acids and derivatives such as TMAO, betaine, L-proline, L-α-
alanine, β-alanine, and glycine reduced the ratio, suggesting that these
compounds increased the homogeneity of the signal intensities. The
average Irel values of the 50 weakest peaks were greater under the
neutral-amino acid and derivative conditions than under the no-
additive condition (Fig. 2D). The values were markedly high under the
L-α-alanine and glycine conditions. These results suggested that the
increase in the Irel of weak signals contributed to the decreased ratio of
the standard deviation to the average. The improvement observed in
the quantitative analysis was conﬁrmed qualitatively in the spectra
(Fig. 3).
Next, we asked whether increasing concentration of L-α-alanine and
glycine further improved the quality of the spectra (Supplementary
Table 2). Average Irel for the 210 amide peaks was greater under the
condition with 0.5 M L-α-alanine than under the conditions with 0 and
1.0 M L-α-alanine. Similarly, average Irel for the 210 peaks was the
greatest under the condition with 0.5 M glycine compared with the
conditions with the other glycine concentrations. In contrast, the more
the concentration of the additive amino acid was, the smaller the ratio
between the standard deviation and average of Irel of the amide peaks
was.
3.4. NMR proﬁles
NMR proﬁling is useful for assessing the distribution of Irel values of
proteins [26]. We proﬁled the Irel values of backbone amide protons
from the 1H–15N HSQC spectra (Fig. 4). Most plots in the NMR-proﬁles
of 1,4-diaminobutane, 1,5-diaminopentane, glycerol, Na2SO4, NDSB
195, NDSB 201, and hydroxyectoine (red data points) were lower than
those in the NMR-proﬁle under the no-additive condition (blue data
points). Between peak numbers ~ 15 to 210, the plots for CHAPS,
trehalose, (L-arginine)2SO4, and L-arginine L-glutamate salt showed
lower Irel values than observed with the no-additive condition, whereas
the Irel values tended to be higher than observed with the no-additive
condition between peak numbers 1 to ~ 15. With L-α-alanine and
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Fig. 1. 1H-15N HSQC spectra with or without additives Overlay of PB2 627 spectra
without additives and (A) with L-arginine L-glutamate salt or (B) with glycine. The boxed
peaks were markedly moved.
Fig. 2. Analysis of the homogeneity of Irel of backbone amide signals The vertical
axes indicate the standard deviation (A), average (B) and the ratio of the standard de-
viation to the average (C) of Irel, respectively. The vertical axis of (D) indicates the
average Irel of the weakest 50 peaks. Lane 1: 1,4-diaminobutane; lane 2: 1,5-diamino-
pentane; lane 3: CHAPS; lane 4: glycerol; lane 5: trehalose; lane 6: Na2SO4; lane 7:
NDSB195; lane 8: NDSB201; lane 9: hydroxyectoine; lane 10: (L-arginine)2SO4; lane 11: L-
arginine L-glutamate salt; lane 12: TMAO; lane 13: betaine; lane 14: L-proline; lane 15: L-
α-alanine; lane 16: β-alanine; lane 17: glycine; lane 18: no additive. Red bars indicate the
values obtained in the absence of additives.
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glycine, most plots for peak numbers between ~ 15 and 210 showed
higher Irel values than observed with the no-additive condition, whereas
the plots under these additive conditions and no-additive condition
were superimposable for peak numbers 1 to ~ 15. The plots for β-
alanine showed lower Irel values compared to the no-additive control
between peak numbers 1 to ~ 15 and were superimposable between
peak numbers ~ 15 to 210. Similar tendencies are observed in the cases
of TMAO, betaine, and L-proline.
4. Discussion
We expressed and puriﬁed 15N-labeled PB2 627, which has a nu-
clear localization signal and a C-terminal RNA-binding domain. The
1H–15N HSQC data indicated that the protein was folded, and was not
aggregated in solution. This observation is consistent with the previous
success in crystallizing PB2 627 [11–13], a process that would have
required a stably folded protein. However, peaks due to backbone
amides varied in intensity, suggesting that transient structural changes,
structural polymorphisms, local denaturation, and/or transient, non-
speciﬁc interactions occurred. Therefore, we collected spectral data in
the presence of various additives that may change the structural
properties of PB2 627 and improve the spectra. Consequently, we found
that TMAO, betaine, L-proline, L-α-alanine, β-alanine, and glycine im-
proved the spectral quality by increasing the homogeneity of signal
intensities, whereas the other compounds did not. In addition, L-α-
alanine and glycine markedly improved the average ratio of intensity of
individual signals to noise levels (i.e., the Irel values).
A natural question is why these compounds improved the quality of
the spectral data. These compounds are osmolytes, which are naturally
occurring chemical chaperones [15,20,22] that enhance hydration of
partially denatured proteins to prevent complete denaturation and
oligomerization/aggregation [27,28]. Thus, the ability of these ad-
ditives to homogenize the structural state of PB2 627 and improve the
spectral quality was not surprising. The NMR proﬁles showed that L-α-
alanine and glycine improved Irel values, except for those with small
peak numbers (i.e. those with high Irel values), which suggests the oc-
currence of decreased structural polymorphisms and/or line broadening
due to local motion over a time scale ranging from microseconds to
milliseconds. In contrast, Irel values with small peak numbers did not
change compared with those observed under the no-additive condition,
suggesting that the mobility of the unstructured regions of PB2 627 was
unchanged. Although most amide peaks did not move upon the addi-
tion of glycine, a few peaks moved upﬁeld, as shown in Fig. 1B, which
may suggest that hydrogen bonds were weakened. This, in turn, may
suggest that transient interactions between PB2 627 monomers or be-
tween PB2 627 and solutes decreased upon the addition of glycine, with
increased hydration. Indeed, the quality of the spectrum of PB2 627
decreased when we increased the concentration of PB2 627, which
suggested non-speciﬁc interaction between monomers of PB2 627
(Supplementary Table. 3). L-α-alanine and glycine have low carbon
contents, each with no more than three carbon atoms, and have mul-
tiple hydrophilic groups. In the cases of TMAO, betaine, L-proline, and
β-alanine, the Irel values with small peak numbers decreased compared
with those observed in the absence of additive, which suggests that
these compounds decreased the mobility of the unstructured regions.
Although these compounds did not improve the average Irel, it is in-
triguing that they improved the ratio between the standard deviation
and the average of Irel through an alternative mechanism to that of L-α-
alanine and glycine. These compounds contain 3–5 carbon atoms with 1
or 2 hydrophilic group(s); thus, they are smaller than detergents and
sugars. Remarkably, the eﬀects of L-α-alanine and β-alanine were dis-
similar, although these amino acids have identical chemical formulas.
We note that these isomers diﬀer in terms of water solubility and other
characteristics, despite their high structural similarity.
No other additives tested improved the quality of the spectral data.
In particular, polyols and sugars such as trehalose and sucrose resulted
in extensive degradation of the spectra. This result was perhaps due to
their higher molecular weight or the presence of aldehyde groups in
sugars. In addition, the bulky amino acid hydroxyectoine, as well as
compounds with relatively large hydrophobic groups, including 1,5-
no additive glycine
strong signal
strong signal
weak signal
weak signal
A B
Fig. 3. Comparison of amide peaks, with or without glycine A region in the 2D 1H–15N HSQC spectrum (A) without or (B) with glycine. Boxed peaks showed diﬀerent intensities
between (A) and (B).
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diaminopentane, CHAPS, β-octylglucoside, and NDSBs, did not improve
the quality of the spectra. Notably, hydrophobic molecules may either
stabilize or destabilize proteins by interacting with hydrophobic pat-
ches on the surface, or with the hydrophobic core, respectively [27,28].
Thus, the data may suggest that these hydrophobic additives mainly
interacted with the hydrophobic core of PB2 627, presumably because
hydrophobic patches on the PB2 627 surface are relatively small. In
fact, there are only 2 aromatic amino acids on the surface: F76 and
Y170 (Supplementary Fig. 4). Accordingly, L-arginine, which is fre-
quently used to stabilize hydrophobic groups on protein surfaces [29],
also degraded the spectra. In the presence of L-arginine, the Irel of peak
numbers ranging from 1 to ~ 15 increased, suggesting that the extent of
mobility of the unstructured regions increased. It has been reported that
L-arginine L-glutamate salt is eﬀective in improving NMR spectra over a
concentration range of 0.05–0.77 M [15,16]. High concentration of
salts causes decreased S/N ratios with modern cryoprobes, so the pos-
sibility remains that lower concentrations of L-arginine L-glutamate and
other salts provide a diﬀerent result. The inorganic salt Na2SO4 also
degraded the quality of spectral data, although SO42- appears early in
the Hofmeister series. This may be because SO42- is not electrically
neutral, as is L-glutamate, which also did not improve the quality of the
NMR data.
Other biophysical screening methods used to optimize solution
conditions, such as dynamic light scattering and the Thermoﬂuor assay,
may be easier than the present NMR-based method to check the eﬀects
of additive compounds on propensities for aggregation and thermo-
stability, respectively. It is, however, quite diﬃcult to study the prop-
erties of local structural dynamics and polymorphisms by those bio-
physical methods, which NMR sensitively detects.
The HSQC spectrum of PB2 627 showed well-dispersed amide sig-
nals, suggesting that global folding is stable in aqueous solution, in line
with its apparent crystallizability [11–13]. However, the intensities of
backbone amide peaks were quite inhomogeneous, indicating that the
protein structure and dynamic properties of PB2 627 are in-
homogeneous. Therefore, we collected NMR data in the presence of
various additives to examine whether those compounds homogenize
the structural state of PB2 627. We compared the resulting spectra using
the ratio between the standard deviation and average of Irel of the
Fig. 4. NMR-proﬁle of PB2 627, with or without
additives The NMR proﬁles of the 18 conditions
tested in Fig. 2 are shown. The longitudinal and
horizontal axes show the Irel values and peak num-
bers, respectively. The conditions are numbered
identically as done in Fig. 2. Plots for each individual
additive conditions are shown with red dots, and
data points obtained with the no-additive condition
are shown with blue dots as a reference.
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amide peaks, which represents a novel approach for assessing NMR data
quality. Based on this analysis, we found that small osmolytes could
improve the quality of NMR spectra by increasing homogeneity of the
structural states of PB2 627. Among these compounds, L-α-alanine and
glycine remarkably improved the Irel of weak signals, which is ad-
vantageous for 3-dimensional measurements. The NMR proﬁles in-
dicated that these additives inﬂuenced the dynamic properties of PB2
627. In contrast, hydrophobic additives did not improve the quality of
the spectra, presumably because such compounds perturbed the folding
of PB2 627 by interacting with its hydrophobic core. These results will
facilitate future structural and dynamics studies of PB2 627 in solution,
as well as drug design targeting PB2 627.
It has been reported that L-α-alanine and glycine stabilize proteins.
Matthews and Leatherbarrow reported that glycine up to 2 M con-
centration increased the thermal stability of the folded structure of ly-
sozyme [30]. The mechanism by which L-α-alanine and glycine stabilize
protein structures is through hydration of protein molecules [20]. The
hydration properties of these amino acids are common with other sta-
bilizing chemicals such as glycerol and L-arginine L-glutamate salt.
Thus, we anticipate that these small amino acids could be generally
applied to stabilize other proteins.
Our results and methodologies will also help develop NMR, che-
mical, pharmacological, and quality-control techniques for analyzing
protein drugs, which are now increasingly used as therapeutics. In
addition, our methods will also help identify, evaluate, or develop
stabilizing agents for such protein drugs, which are generally much less
stable than small molecules.
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